Genetically engineered fusion proteins for treatment of cancer.
Year: 2012
Type: article
Source: PubMed
Institution: Roche Pharma AG (Germany)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2127804975
